• liver

FDA approves first drug for fatty liver

The US Food and Drug Administration (FDA) yesterday approved Madrigal Pharmaceuticals' drug for the treatment of fatty liver disease known as non-alcoholic steatohepatitis (NASH). This is the first treatment to receive approval for the condition, opening up an opportunity for the company worth billions of dollars. NASH, more recently known as "metabolic dysfunction-associated steatohepatitis" ...

FDA approves first drug for fatty liver Read More »